Madhan Thamilarasan

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo”.

Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo

Blood Advances(2020)10.1182/bloodadvances.2020001642

N/A

0DataRank · unranked

23 citations

Rodolfo Estupinan, Ines Batinic̈‐Haberle, Rahima Zennadi, Madhan Thamilarasan

STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways

The Journal of Immunology(2021)10.4049/jimmunol.2001317

N/A

0DataRank · unranked

33 citations

Toru Uchimura, Matthew D. Gallovic, Madhan Thamilarasan, Wei-Chun Chou, Sara A. Gibson +10 more

Cilia proteins are biomarkers of altered flow in the vasculature

JCI Insight(2022)10.1172/jci.insight.151813

N/A

0DataRank · unranked

13 citations

Karthikeyan Thirugnanam, Madhan Thamilarasan, Ashraf M. Mohieldin, Hadeel T. Zedan, Shubhangi Prabhudesai +10 more